Navigation Links
ValGenesis Announces Strategic Partnership with VTI Life Sciences
Date:9/19/2017

SAN FRANCISCO, Sept. 19, 2017 /PRNewswire/ -- ValGenesis Inc., the global leader in Enterprise Validation Lifecycle Management Solutions (VLMS) is pleased to announce the strategic partnership with VTI Life Sciences (VTI). This partnership enables VTI to provide clients with validation services using the latest technology available in the ValGenesis VLMS system. As a partner, VTI will provide clients with efficient and cost-effective validation services using ValGenesis VLMS. VTI will also be a marketing partner for the ValGenesis VLMS system.

The partnership between ValGenesis and VTI creates a fully comprehensive and innovative approach towards providing validation services using an integrated paperless validation lifecycle management platform. Life science companies will benefit greatly from VTI's validation expertise and their knowledge of the ValGenesis VLMS platform.

"We are pleased to be a strategic technology partner with VTI and look forward to enhanced efficiency, enabled compliance and reduced costs of Validation lifecycle processes through ValGenesis VLMS," said Siva Samy, CEO of ValGenesis "We share the same vision, which is providing customers with validation services through VLMS so as to satisfy their every need."

President of VTI, Herb Matheson, adds: "VTI looks forward to the partnership with ValGenesis and the team of technology experts that ValGenesis represents. Together, VTI and ValGenesis look to providing industry leading, turn-key VLMS integration and support to our customers.  We look forward to better serving our clients through this partnership."

ValGenesis is a comprehensive leading paperless validation lifecycle management solution in the life science industry that allows customers to fully automate the validation process, eliminate inefficiencies found in paper based manual processes, while also reducing costs and validation cycle times.  The ValGenesis Validation Lifecycle Management System (VLMS) effectively manages all types of validation activities such as equipment, instruments, computer systems, cleaning, analytical methods, and process validation. ValGenesis' VLMS covers the entire validation lifecycle thereby delivering technology solutions that are validated, fully configurable and rapidly deployable through onsite or by way of a validated secured cloud environment.

VTI Life Sciences, an ISO 9001:2008 Certified Global Company, strives to maintain and inspire professional excellence by providing Validation, Commissioning, and Qualification (C&Q) Services to Pharmaceuticals, Biotechnology, Biologics, Medical Devices and FDA/Internationally regulated industries.  VTI has the experience, expertise, and demonstrated leadership that provides premier validation and compliance consulting services to life science clients.

About ValGenesis

ValGenesis, Inc. is the creator of an innovative software platform serving as the foundation for managing compliance-based validation activities in Life Sciences companies. ValGenesis, Inc. provides the first enterprise application to manage the corporate validation lifecycle process. As the only system for managing validation execution and approval 100% electronically, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award. The solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. For more information, visit ValGenesis' website at http://www.valgenesis.com.

About VTI Life Sciences

VTI Life Sciences provides superior service and expertise required to meet life science industry validation needs.  Founded in 1996, VTI offers a full range of validation and quality system services for a cGMP/GLP facility.  VTI validation professionals have hands-on experience and subject matter expertise in Facility Design and Construction, Utility Systems, Process Equipment, Process Qualification and Computerized Systems Validation.

VTI offers a full spectrum of services such as computer validation, cleaning validation, process validation, clean room certification, temperature mapping, process equipment, facility qualification, and much more. Dedication to quality, personalized support and the success of client projects are at the foundation of the company.

As a leading worldwide consulting firm, the basis of VTI's business is founded on dedication to quality, personalized support, and the success of projects. VTI offices are located in San Diego, San Francisco, Boston, and China.

For more information, visit www.valgenesis.com, www.validation.org

Media contact:
Mike Beaudro
177091@email4pr.com 
510 445 0505

View original content with multimedia:http://www.prnewswire.com/news-releases/valgenesis-announces-strategic-partnership-with-vti-life-sciences-300521946.html


'/>"/>
SOURCE ValGenesis Inc
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. ValGenesis Inc. Successfully Completes ISO 9001:2008 Surveillance Audit
2. ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101
3. Band-LOK Announces Allowance for Two New U.S Patents for the Tether Clamp and Implantation System
4. OAI Announces Multiple Orders for Advanced, Model 6000, Production Mask Aligners
5. Lifecycle Biotechnologies Announces Promotion of Ashley Wilhelm to Customer Outcomes Manager
6. Cynvenio Announces New LiquidBiopsy® Test for PD-L2 Expression
7. PRC Clinical Announces Completion of First Patient Cohort in UC Davis Regenerative Medicine Study in Musculoskeletal Diseases
8. ExcitePCR Announces its FireflyDX-Portable: A Lightweight, Bookbag-sized Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018
9. American Farmer Announces Episode, Featuring Federal Hybrids, Inc.
10. BioLife Solutions Announces Second Quarter 2017 Financial Results
11. HumanZyme® Announces Human Cell-Expressed Interferon beta for Immunology and Immunotherapy Research Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... At its ... Dr. Christopher Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has ... was a member of the winning team for the 2015 Breakthrough Prize in Fundamental ...
(Date:10/9/2017)... Texas (PRWEB) , ... October ... ... study published on October 5, 2017, in the medical journal, Epilepsia, Brain ... with the gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C kit. ... to perform Hi-C metagenome deconvolution using their own facilities, supplementing the company’s ...
(Date:10/6/2017)... ... 2017 , ... The HealthTech Venture Network (HTVN) is proud ... annual Conference where founders, investors, innovative practitioners and collaborators are invited to a ... early stage digital health and med tech companies. , This day-long event will ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
Breaking Biology News(10 mins):